Overview: Estriol (E3) TestIntroduction: The Estriol (E3) Test measures unconjugated estriol to assess fetal health during pregnancy, monitoring risks like preterm labor. Aligned with 2023 ACOG guidelines, it uses an immunoassay for high sensitivity, aiding in pregnancy screening. This test is critical for guiding prenatal care, monitoring fetal health, and improving outcomes in endocrinology for pregnant patients.
Other Names: uE3 Assay, Unconjugated Estriol Test.
FDA Status: Laboratory-developed test (LDT), meeting endocrinology standards for diagnostic accuracy.
Historical Milestone: Estriol testing began in the 1970s with prenatal research. Immunoassays for unconjugated estriol emerged in the 1980s, and by the 2000s, high-sensitivity assays improved accuracy.
Purpose: Assesses fetal health, guides prenatal care, and monitors estriol levels in pregnant patients at risk of preterm labor.
Test Parameters: 1. Unconjugated Estriol
Pretest Condition: Fasting for 10-12 hours required to stabilize hormone levels. Collect serum, plasma, or urine in the morning. Report pregnancy stage, symptoms like preterm labor, and list medications.
Specimen: 2-5 mL serum (SST), 2-4 mL plasma (EDTA), or 50-100 mL urine (24-hour collection, sterile container). Centrifuge serum/plasma within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document pregnancy stage, preterm labor risks, or fetal health concerns. Include current medications, especially prenatal supplements.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for prenatal interventions.
Procedural Considerations: Uses an immunoassay to measure unconjugated estriol levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting, improper collection, or medications can affect results. Hemolysis may degrade samples.
Clinical Significance: Low estriol levels suggest fetal distress or preterm labor risk, prompting intervention. Normal levels support healthy pregnancy monitoring.
Specialist Consultation: Consult an obstetrician or maternal-fetal medicine specialist for result interpretation.
Additional Supporting Tests: AFP, hCG, or ultrasound to assess fetal health.
Test Limitations: Results may be affected by medications or non-fetal factors. Clinical correlation is required.
References: ACOG Prenatal Guidelines, 2023; Obstetrics & Gynecology, Wapner RJ, 2022.
